Among the more than 75 known variants of a 1 -proteinase inhibitor, a sub-population of rare, point mutations causing single amino acid replacements have been identified and classified as ''at risk'' alleles for development of pulmonary disease. In most cases, it is not clear how the amino acid replacements typical of these variants change the properties of the inhibitor to increase risk of disease in the affected individuals. To begin to address this question, we mutagenized a wild type a 1 -proteinase inhibitor cDNA to encode a panel of eight different point mutants reported to be associated with increased risk for development of pulmonary disease. These variants were then expressed in COS-l cells transiently transfected with plasmids containing the altered cDNAs. The effects of the mutations on the rates of secretion, cellular location, intracellular degradation, activity, stability, and tendency to aggregate were determined. Results of these studies show that, in some cases, the mutations affect the rate of secretion, the activity or both of these properties of a 1 -proteinase inhibitor in a manner consistent with its designation as an ''at-risk'' allele. In other cases, the mutations do not significantly change the properties of the inhibitor, suggesting that these may be normal variants and that their expression may not increase the risk of disease. D
Introduction
Human alpha l-proteinase inhibitor (a 1 Pi, a 1 -antitrypsin) 1 , a member of the serpin super family of proteins, is the major serine protease inhibitor in the circulation and functions primarily to inhibit elastase released from activated or disintegrating neutrophils [1] . A deficiency of circulating a 1 Pi is associated with pulmonary emphysema and childhood liver disease [2, 3] . The pulmonary damage appears to be a direct result of the failure to adequately control the activity of the neutrophil elastase either due to too little circulating inhibitor, to the lack of activity of the secreted a 1 Pi, or to a combination of both. While a number of variants of a 1 Pi have been described, most individuals express the normal M allele [4] and have circulating levels of a 1 Pi in the range of 104 to 276 mg/dl [3] . Serum levels of active a 1 Pi above 57 mg/dl are adequate to protect the lung from elastase digestion [3] . If serum levels of a 1 Pi fall below this threshold or if the circulating inhibitor is an inefficient inhibitor of elastase, lung damage leading to emphysema can result.
The Z allele is most commonly associated with a deficiency state severe enough to cause disease [3] . Individuals homozygous for this allele or who express it in combination with other deficiency alleles, are at risk of developing emphysema and/or liver disease. These individuals appear to produce normal amounts of a 1 PiZ to transport the protein into the lumen of the endoplasmic reticulum (ER), but are unable to efficiently transport the protein from the ER to the Golgi apparatus [5 -7] . The inefficiently secreted a 1 PiZ is largely degraded, probably by a mechanism involving ubiquitination, retro-translocation into the cytosol, and subsequent degradation by the proteasome [8] [9] [10] . Smaller amounts of a 1 PiZ accumulate as inclusion bodies in cells expressing this variant [11] . Accumulation of a 1 PiZ and formation of inclusion bodies is thought to lead to the liver damage occurring in about 15% of the Z homozygotes [12] . The basis for the liver damage is not well understood but expression of a 1 PiZ in skin fibroblasts isolated from the different populations of Z homozygotes indicate that those who develop liver disease are less able to degrade the retained a 1 PiZ [13] . As a result of the inefficient secretion of the Z variant, the circulating levels of this form of the inhibitor are well below the 57 mg/dl threshold needed to protect the lungs. The severity of the deficiency state is probably magnified due to a reduction in the ability of a 1 PiZ to inhibit elastase [14] . Both the inefficient secretion and the reduction in the activity of the inhibitor result from a point mutation leading to the replacement of Glu 342 with Lys [6, 7, 15] . The means by which this mutation causes the altered properties of a 1 Pi are not known.
While the Z allele is found at a frequency of about 0.01 to 0.02 in many populations [2] , other rarer variants of a 1 Pi harboring single amino acid replacements have been reported to be associated with pulmonary disease. None of these rare variants has been as thoroughly studied as a 1 PiZ and the consequences of these mutations upon the properties of a 1 Pi are largely unknown. This study was undertaken to systematically compare the rates of secretion, the stabilities, the sites of accumulation, and the activities of eight of these rare variants after their expression in Cos cells. The variants studied are: a 1 PiI, Arg 39 YCys [16] ; a 1 PiM procida , Leu 41 YPro [17] ; a 1 PiS iiyama , Ser 53 YPhe [18] ; a 1 PiM mineral springs , Gly 67 YGlu [19] ; a 1 PiQO ludwigshafen , Ile 92 YAsn [20] ; a 1 PiP lowell , Asp 256 YVal [21] ; a 1 PiW bethesda , Ala 336 YThr [22] ; and a 1 PiM heerlen , Pro 369 YLeu [23] .
Materials and methods

Reagents
Porcine pancreatic elastase (type IV) and human leukocyte elastase were purchased from Sigma Chemical Co. (St. Louis, MO). Kits for mini preparation of plasmid DNA and for extraction of DNA fragments from agarose gels were obtained from Qiagen Inc. (Chatsworth, CA). Restriction enzymes, T4 DNA ligase, calf intestinal phosphatase and Hams F-12 growth medium, complete and methionine free, were provided by GibcoBRL (Grand Island, NY). Vent R 
Site directed mutagenesis
The production of all of the variants except a 1 PiQO ludswigsbafen and a 1 PiW bedmsda was accomplished by use of the recombinant polymerase chain reaction (RPCR) [24] to change the appropriate nucleotide in pSV7a 1 PiM to yield the necessary amino acid change. The polymerase chain reactions for each mutation were carried out at three different concentrations, 1, 10, and 100 ng, of alkali denatured pSV7a 1 PiM [25] . The other components of the reaction mixtures were 0.8 AM of the appropriate primers (Table 1) , 0.2 mM of all four deoxynucleotide triphosphates, 2 units of Vent R polymerase, 10 mM KC1, 20 mM Tris -HCI (pH 8.8 at 25 -C), 10 mM (NH 4 ) 2 SO 4 , 3 mM MgSO 4 in a final volume of 100 Al. The reactions were carried out in a BioOven thermocycler (BioTherm Corporation, Arlington, VA) programmed for cycles of 1 min denaturation at 94 -C, 50 s annealing at 60 -C; and 5 min elongation at 72 -C. At the end of 30 cycles, the reactions were maintained at 72 -C for 10 min to encourage completion of full-length product. The products were linear, blunt-ended, double-stranded DNAs with identical overlapping ends that contained the complete plasmid sequence (3679 to 3682 nucleotides, depending upon the primer set used). The linear DNA fragments were purified by electrophoresis through 1% agarose gels, excising gel slices containing the appropriately sized fragment, and extracting the DNA using a DNA gel extraction kit. One to 10 ng of the purified, linear DNA was introduced into electrocompetent E. coli DH5-a (40 Al of a suspension of 2 Â 10 10 cells/ml in a chilled 0.1 cm cuvette) by electroporation using a Bio Rad-Gene Pulseri (BioRad, Hercules, CA) with setting of 25AF, 1.65 kV, and 200 V. The electroporated cells were incubated in SOC medium (2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM NaCl, 2.5 mM KCI, 10 MM MgCl 2 , 10 mM MgSO 4 , 20 mM glucose) at 37 -C for 1 h, plated onto ampicillin selective medium and incubated over night at 37 -C. Three milliliter aliquots of L broth were inoculated with cells from 4 to 6 of the resulting colonies and incubated overnight at 37 -C. Plasmid DNA was prepared from these cultures by standard procedures [26] and purified using a DNA purification kit following the manufacturer's directions. The regions of the plasmids that potentially contained the desired mutation were then sequenced using appropriate primers and the TaqTrack Deaza Sequencing System according to the manufacturer's directions (Promega Corp., Madison, WI). Those found to have the necessary base changes were selected to complete construction of the vectors.
To eliminate possible errors resulting from the PCR reactions, a plasmid containing the desired mutation was reconstructed from appropriate sequences derived from the plasmid produced by RPCR and from pSV7a 1 PiM. To accomplish this, a fragment of the PCR product containing the point mutation was excised with restriction enzymes that recognized unique sites flanking the mutation. pSV7a 1 PiM was digested with the same endonucleases and the sequence required to reconstruct the desired plasmid was isolated. The two isolated fragments were then ligated using T4 DNA ligase to yield a new construct composed largely of sequences from pSV7a 1 PiM, i.e., only the fragment containing the mutation was derived from the plasmid produced by RPCR. Since the fragment from pSV7a 1 PiM should be unaltered, only the region containing the PCR generated insert was sequenced. After confirming that a plasmid contained the desired mutation, a large-scale preparation of that plasmid was performed using cesium chloride equilibrium density centrifugation as the final purification step [26] .
Since the base changes required to produce a 1 PiQO ludwigshafen (A 361 YT) and a 1 PiW bethesda (G 1092 YA) are both located in a region flanked by unique sites for the restriction enzymes BspE1 (site at nucleotide 347) and Cla1 (site at nucleotide 1104), primers were designed (Table 1) to incorporate the unique restriction sites and to introduce these mutations near the ends of the 767 base pair PCR product. PCR was carried out using alkaline denatured pSV7a 1 Pi M as template and the product purified as described above. This material was digested with BspE1
and Clal and the product containing both mutations was ligated into a similarly digested pSV7a 1 Pi M to yield a plasmid containing a a 1 Pi cDNA that encoded a double mutant with the changes reported for both a 1 PiQO ludwigshafen and a 1 PiW bethesda . At this point, a portion of the plasmid originating from PCR was sequenced to confirm that the mutations had been produced. This plasmid was digested with BspE1 (site at nucleotide 347) and BstEII (site at nucleotide 722) to yield a 375 by fragment containing the mutation required for a 1 PiQO ludwigshafen and with EcoRV (site at nucleotide 894) and Clal (site at nucleotide 1104) to yield a 210 by fragment containing the mutation required for a 1 PiW bethesda . These fragments were then used to replace the corresponding sequences in pSV7PiM to generate pSV7PiQO ludwigshafen and pSV7PiW bethesda . The regions in these plasmids that originated from the PCR reaction were sequenced to confirm that the correct constructs had been obtained.
Cell growth and transient transfection
COS-1 cells (American Type Culture Collection, Rockville, MD) were cultured and transiently transfected by electroporation as described previously [27] .
Pulse-chase analyses
Identical aliquots (À1 Â10 6 cells) of the COS-1 cells transiently transfected with a plasmid encoding one of the variants were plated into the wells of a 6-well dish and In each case, the sequence of primer 1 corresponds to the sequence of the coding strand and the sequence of primer 2 is complementary to the sequence of the coding strand. The subscripts identify the position of the nucleotide relative to the coding strand. The nucleotides in bold designate base changes incorporated to produce the desired variant. The underlined nucleotides indicate the sequences encoding the identical ends of the linear PCR products where recombination occurs. a 1 PiQO ludwigshafen and a 1 PlW bethesda were not constructed by RPCR, but rather by an alternative, PCR-based strategy and in these cases, the sequences identified by the dotted underlines indicate sites recognized by the restriction enzymes BspE1 (site at nucleotide 347) and Cla1 (site at nucleotide 1104). a The nucleotide change responsible for the amino acid change characteristic of each of the variants is indicated in bold. b In the numbering system used, the A of the ATG initiation codon in a 1 Pi cDNA is designated as nucleotide number 15 and the T of the TAG termination codon is designated as nucleotide number 1269. incubated for 48 h to allow amplification of the plasmid and synthesis of the mRNA encoding the Pi variant. The cells were then incubated for 1 h in methionine-free growth medium to deplete the intracellular methionine pool. The medium in each well was then replaced by 600 Al of medium containing 100 ACi [ 35 S]-methionine/ml and incubated 30 min to metabolically label proteins. The cells were washed, placed into standard growth medium, and incubated 10 min to allow completion of nascent chains initiated in presence of the [ 35 S]-methionine [28] . At this point, the growth medium was changed and sample collection initiated. At the indicated times, growth media were collected and cells were lysed directly on the plates with chilled lysis buffer (12.5 MM sodium phosphate (pH 7.5), 125 mM NaCl, 2 mM phenylmethylsulfonyl fluoride (PMSF), 0.5% deoxycholic acid, 1% Triton X-100).
Immunoprecipitation and SDS-PAGE analyses
The protocols described earlier were used for these procedures [27] . Quantitative analyses of the SDS-PAGE gel patterns were performed by phosphorimaging using a Model 400 E Phosphorimager (Molecular Dynamics, Sunnyvale, CA).
Immunofluorescence
COS-1 cells, transiently transfected with the appropriate plasmids as described above, were grown on cover slips, permeabilized, and immunostained using affinity-purified rabbit anti-human Pi as primary antibody and fluorescein isothiocyanate-goat anti-rabbit IgG as secondary antibody. Details of the staining procedure as well as of the subsequent observation and photography of these cells were described earlier [29] .
Formation of SDS-stable complexes between Pi and elastase
Two procedures were used to examine the ability of the Pi variants to form SDS-stable complexes with elastase. In the first, transiently transfected COS-1 cells were grown to approximately 80% confluence on 100 mm plates under standard conditions, incubated to deplete the intracellular methionine pool, and then metabolically labeled by a 30min incubation in 3 ml of methionine free medium to which 0.2 mCi [ 35 S]-methionine had been added (see above). To obtain 35 S-labeled, intracellular material, the cells were scrapped from the plate immediately after labeling, transferred to 15 ml centrifuge tubes, washed 3 times with ice cold 12.5 mM sodium phosphate containing 125 mM NaCl (pH 7.5) and lysed in 0.2 ml of the same buffer containing 1.5% Triton X-100. To obtain secreted 35 S-labeled proteins, the metabolically labeled cells were transferred to 3 ml of serum-free Ham's F12 medium, incubated for 1 h, the growth medium collected and concentrated to 200 Al by centrifugation through a Centricon 30 concentrator (Amicon Inc., Beverly, MA). The lysates and the concentrated growth medium were then centrifuged at 10,000 Â g, 4 -C for 10 min to remove debris. Forty Al aliquots of the resulting supernatant fractions were transferred to tubes containing 0, 5, 10, 25, and 50 pmol of porcine pancreatic elastase (2 Â 10 À3 units/pmol) in a total volume of 0.6 ml of cold 12.5 mM sodium phosphate containing 125 mM NaCl (pH 7.5), and incubated on ice for 30 min. At this point, 0.6 ml of 12.5 mM sodium phosphate buffer (pH 7.5) containing 125 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.5% SDS, 2 mm PMSF, 6 Ag/ml aprotinin, and 1 mg/ml bovine serum albumin was added. These samples were immunoprecipitated using affinity purified rabbit anti-human Pi and the immunoprecipitates analyzed by SDS-PAGE and phosphorimaging as described above. Formation and analyses of stable complexes between secreted, 35 S-labeled forms of a 1 Pi and human leukocyte elastase were performed as specified above except that 0.04 units of elastase were used in all cases.
The second procedure was carried out essentially as just described except that the cells were not metabolically labeled and 125 I-labeled elastase was used for complex formation. The 125 I-elastase was prepared using the IODO-GEN Iodination Reagent as recommended by the manufacturer (Pierce, Rockford, IL).
Transverse urea gradient (TUG) polyacrylamide gel electrophoresis
Gels for TUG [30] were poured using a gradient maker purchased from Buchler Instruments (Fort Lee, NJ). The acrylamide solutions were prepared as described by Laemmli [31] , but without SDS. The first chamber contained a 7.5% acrylamide solution that was 8 M in urea and the second chamber contained an equal volume of 10% acrylamide. Vertical, linear gradients of 0 to 8 M urea and a 10 to 7.5% compensatory inverse gradient of polyacrylamide [30] were formed by pumping these solutions into plates held in a minigel apparatus (Bio-Rad, Hercules, CA). After polymerization, the cast gel was rotated 90-to produce the horizontal gradients required for these analyses. Intracellular and secreted material for TUG analyses was obtained from transiently transfected COS-1 cells (1.5 Â 10 7 cells) grown in 150 cm 2 plates. Seventy-two hours post-transfection the growth mediaphenylmethylsulfonyl fluoride were replaced with 10 ml of serum-free F12 medium and incubation continued overnight (~16 h). The growth media were then collected and concentrated~100-fold (final volume adjusted to 100 Al) in a Centricon-30 concentrator to obtain an adequate concentration of secreted material for analysis. The cells were washed with PBS, scraped from the plates, transferred to tubes and pelleted by centrifugation. The pellet was suspended in 100 Al of PBS containing 1 mM PMSF and disrupted by sonication (Cell Disruptor, Model W-220f, Sonicatori Heat Systems-Ultrasonics, Inc., Plainview, NY), rather than detergent lysis, to minimize potential problems from nonionic detergent induced aggregation of normal serpins at slightly elevated temperature [32] and of certain mutant serpins at room temperature (W. Hahn and J.L. Brown, unpublished results). After sonication, cell debris was removed by centrifugation and the supernatant fraction used as a source of intracellular serpin. For TUG analyses, samples were diluted with an equal volume of 2 Â sample buffer [26] containing no reducing agent or SDS, 100 Al aliquots were layered across the tops of the gels and electrophoresis was carried out for 2.5 h at 20 mA. The gels were removed from the plates and the proteins electrophoretically transferred [33] using a Mini Trans-Blot-Cell (Bio-Rad, Hercules, CA) at 14 V, overnight at 4 -C, to Immobiloni-P transfer membranes (Millipore, Bedford, MA). After blocking [33] , the membranes were transferred to 5 ml of fresh blocking buffer containing 5 Ag of affinity purified rabbit antihuman a 1 Pi [29] for 2 h at 25 -C, washed 3 times for 15 min in 10 ml aliquots of PBS containing 0.05% Tween-20, placed in 5 ml of blocking buffer containing 10 Al of [ 125 I] protein A (specific activity >30 ACi/Ag, ICN) and incubated with rocking for 2 h. The membranes were washed 3 times for 15 min in 10 ml of PBS containing 0.05% Tween-20, air-dried, covered with plastic wrap, placed onto a phosphorimager screen overnight and the patterns observed using a Molecular Dynamics Model 400E PhosphorImager.
Results
Pulse chase analyses of the effects of the rare point mutations on the secretion and degradation of a 1 Pi
The results of these experiments are grouped into three general categories depending upon the properties and fates of the a 1 Pi variants after their expression and labeling with [ 35 S]-l-methionine in COS cells. The mutations producing variants that fall into category 1 have little effect on the secretion or stability of the variant. Based on formation of SDS-stable complexes with elastase, these variants have biological activities ranging from normal to none. Mutations resulting in variants placed into category 2 cause a moderate but definite reduction in secretion of the variant but lead to little or no intracellular degradation. These variants form SDS-stable complexes with elastase and retain the ability to inhibit elastase activity. Mutations responsible for the variants placed into category 3 cause a pronounced reduction in the secretion of the altered proteins and may be associated with an increase in their intracellular degradation. These variants do not form SDS-stable complexes with elastase and they have a tendency to aggregate.
The analyses of the secretion of the variants that fall into the first category, and of the normal a 1 Pi M for comparison, are shown in Fig. 1 . The mutations in a 1 PiW bethesda and a 1 Pi M mineral springs have little or no effect on the secretion or degradation of these proteins. The replacement of Ile 92 with Asp does appear to slow the rate of secretion of a 1 PiQO ludwigshafen but little or no intracellular degradation of this protein occurs and as a result, it is well secreted by 2 h of chase. The average percentages of the initial pools of the rare variants that were secreted after 2 h of chase in n experiments and their standard deviations are: a 1 PiW bethesda 91.5 T 3.9% (n = 5), a 1 Pi mineral springs 89.3 T 6.5% (n = 5), and a 1 PiQO ludwigshafen 82.6 T 9.6% (n = 4). ]-l-methionine, transferred to unlabeled growth medium, and incubated for 10 min to allow completion of nascent chains initiated in presence of the label. The cells were then transferred to fresh growth medium and incubation continued. Cells and growth medium were collected at the indicated times. The cells were washed and lysed. The medium and the lysates were treated with rabbit anti human a 1 Pi to precipitate the secreted and cellular a 1 Pi, respectively. The immunoprecipitates were analyzed by SDS-PAGE and phosphorimagery. The data are expressed as percentage of the pool of rabbit anti-a 1 Pi precipitable, 35 Slabeled material present at the start of the chase. The amount of a 1 Pi in the cellular and secreted pools at each time point is indicated by the solid black and hatched bars, respectively. Degradation, represented by the gray bar, is calculated as the difference between the amount of material present at the start of the chase and the sum of the intracellular and secreted material at each time point. The panels below each stacked bar show the bands detected by the phosphorimager that correspond to the secreted (S) and cellular (C) forms of a 1 Pi used for the quantitative analyses. The results of pulse chase analyses of the second class of rare mutations are illustrated in Fig. 2 . Secretion of a 1 PiI and a 1 PiP lowell is reduced compared to a 1 PiM ( Fig. 1 ) and low levels of degradation of these variants were observed in all repetitions of these measurements. The average percentages of the initial pools of these variants that were secreted after 2 h of chase in n experiments and their standard deviations are: a 1 Pi I 38.8 T 6.4 (n = 6) and a 1 PiP lowell 50.6 T 9.2 (n = 5).
Analyses of the fates of the variants that fall into the third class are compared with those of a 1 PiZ, the variant commonly associated with the deficiency state, in Fig. 3 . a 1 PiS iiyama appears to be secreted somewhat more efficiently and to be degraded less rapidly than a 1 PiZ. a 1 PiM heerlen and a 1 PiM procida are even less well secreted than PiZ. Reproducible intracellular degradation was observed in the case of a 1 PiM procida , however, little or no degradation was observed for a 1 PiM heerlen during the 2-h chase period. The average percentages of the initial pools of these variants that were secreted after 2 h of chase in n experiments and their standard deviations are: a 1 PiS iiyama 39.6 T .6 (n = 5), a 1 PiM heerlen 9.6 T 1.1 (n = 4) and a 1 PiM procida 11.5 T 2.5 (n = 5).
Intracellular localization of the a 1 Pi variants expressed in COS cells
The intracellular distribution of the a 1 Pi variants was determined by indirect immunofluorescence of transiently transfected, permeabilized COS-1 cells that were expressing these variants (Fig. 4) . The pattern for the well-characterized M variant is shown for comparison. The staining patterns of a 1 PiW bethesda , a 1 PiM mineral springs and a 1 PiQO ludwigshafen are very similar to that observed for a 1 PiM and may reflect relatively high concentrations of the inhibitor in the Golgi apparatus [6] . These results are consistent with the pulse chase analyses showing that these variants are well secreted and that, with respect to their secretion, they behave in a similar manner to the normal a 1 PiM. a 1 PiQO ludwigshafen was also present in the ER in large enough quantities to produce staining of this organelle. It is likely that staining of both the Golgi apparatus and the ER of cells expressing this variant is a result of its somewhat slower than normal rate of secretion (Fig. 1) . The staining patterns observed in cells expressing a 1 PiI and a 1 PiP lowell may indicate that these variants accumulate in both the ER and the Golgi apparatus.
Cells expressing a 1 PiS iiyam, a 1 PiM procida , and a 1 PiM heerlen exhibited staining of the ER consistent with their accumu- lation in this organelle as would be expected for poorly secreted or unsecreted forms of these proteins. The patterns observed in cells expressing a 1 PiM procida and a 1 PiM heerlen are essentially identical to that observed for the poorly secreted a 1 PiZ. Cells expressing a 1 PiS iiyama , however, exhibited staining of both the ER and the Golgi apparatus. The rate of secretion of a 1 PiS iiyama is comparable to that of a 1 PiI, which is also distributed in both the ER and the Golgi apparatus. The lack of ability of a 1 PiS iiyama to form a SDSstable complex with elastase (see below) combined with its decreased rate of secretion resulted in its classification along with the very poorly secreted a 1 PiM procida and a 1 PiM heerlen .
Reaction of a 1 Pi variants with elastase
To assess the ability of the different variants of a 1 Pi to interact with elastase, the formation of SDS-stable complexes between metabolically labeled a 1 Pi and unlabeled elastase and between unlabeled a 1 Pi and 125 I-elastase was measured. The results shown in Fig. 5 summarize the effects of adding increasing amounts of elastase to a constant, empirically determined, amount of a 1 Pi. These results show that both the secreted and intracellular forms of the normal a 1 PiM and a 1 PiW bethesda form SDS-stable complexes with elastase. The production of two sizes of the complex when the cellular material was incubated with elastase suggests that both the ER and Golgi forms of these inhibitors form SDS-stable complexes with elastase. Quantitation of the a 1 Pi present after incubation with elastase shows that a maximum of approximately 20% of the secreted and cellular forms of both variants form SDS-stable complexes with elastase. In addition to the complex, some unreacted and some faster migrating, cleaved versions of the inhibitors were detected. The intracellular material detected in this assay presents a somewhat more complex pattern due to the presence of two major forms that differ in the structures of their carbohydrate side chains [6] . This can best be seen in the absence of elastase (lane 1). The upper band is the Golgi form and contains complex carbohydrate side chains. The lower band is the ER form and contains high mannose type carbohydrate side chains due to core glycosylation. Both of these forms appear to be competent to form SDS-stable complexes with elastase. In contrast, the other two wellsecreted variants, a 1 PiM mineral springs and a 1 PiQO ludwigshafen , demonstrated no or little ability to form stable complexes with elastase (see Fig. 5 ). Neither the intracellular nor secreted populations of a 1 PiM mineral springs produced detectable quantities of complex with elastase; instead, these forms serve as substrates for this protease and are almost completely converted to a cleaved version at the higher concentrations of elastase. On the other hand, the secreted form, but not the intracellular form, of a 1 PiQO ludwigshafen did produce a detectable level of stable complex with elastase. The amount of complex increased with increasing concentrations of elastase but even at the highest concentration of elastase a maximum of about 2% of the original pool of 35 S-labeled a 1 PiQO ludwigshafen was found to be complexed with this protease. Most of this material appeared to serve as a substrate for elastase.
SDS-stable complexes are produced when either the secreted or intracellular forms of a 1 PiI or a 1 PiP lowell are incubated with elastase ( Fig. 6 ). In these cases, the yields of complex between elastase and the secreted forms of both variants are comparable to those observed for a 1 PiM and a 1 PiW bethesda i.e., a maximum of about 20% of the original pool appears in complex with elastase. Only 8% and 5% of the intracellular pools of a 1 PiI and PiP lowell , respectively, are observed in complex with elastase. These latter results suggest that the 30-min labeling period is not sufficiently long to allow maturation of the intracellular forms of these variants to a point that they can be secreted or that they can form stable complexes with elastase. In these cases, none of the larger complex observed for the intracellular forms of a 1 PiM and a 1 PiW bethesda was detected, probably because the pool present in the Golgi apparatus was too small.
Due to the very low levels of secretion of a 1 PiM procida and a 1 PiM heerlen , only the intracellular forms of the variants placed into category 3 were analyzed for their ability to form SDS-stable complexes with elastase. As indicated in Fig. 7 , no stable complex is observed after reaction of a 1 PiS iiyama , a 1 PiM procida , or a 1 PiM heerlen with elastase. All three of these variants appear to serve as substrates for elastase and to be increasingly degraded as the concentration of elastase is increased. In the case of a 1 PiM procida , discrete bands other than the major clipped form observed for all of the variants are observed suggesting that the mutation leads to a structure that exposes additional sites preferentially cleaved by elastase.
To support the conclusion that the more slowly migrating material observed after reaction of a 1 Pi with elastase represents a SDS-stable complex, the SDS-PAGE patterns of immunoprecipitable products formed by treating samples containing 35 S-a 1 Pi with unlabeled elastase are compared to those produced by treating samples containing unlabeled a 1 Pi with 125 I-elastase. This comparison (Fig. 8) shows that only the more slowly migrating bands corresponding to the putative complexes contain both a 1 Pi and elastase.
The interaction of leukocyte elastase with variants of a 1 Pi that are secreted in large enough amounts to measure was also examined (data not shown). No significant differences in the abilities of the variants to interact with human leukocyte or porcine pancreatic elastase were observed, i.e., a 1 PiW bethesda and a 1 PiP lowell appear to form SDS-stable complexes with the human elastase about as well as a 1 PiM, whereas only a trace of complex with of a 1 PiQO ludwigshafen and no complex with a 1 PiM mineralsprings was observed.
Comparison of the stability's of the a 1 Pi variants to urea denaturation
The relative stabilities of the intracellular and secreted forms of the a 1 Pi variants were examined by transverse urea gradient (TUG) electrophoresis [30] . The patterns observed for the well-secreted variants are shown in Fig. 9 . The unfolding of a 1 PiM produced in transfected COS cells as the urea concentration increases is essentially identical to that reported for normal a 1 Pi isolated from human serum [32] . The unfolding of either the cellular or the secreted form of a 1 PiW bethesda in response to increasing urea concentration does not appear to differ from that of a 1 PiM. On the other hand, both the cellular and secreted forms of a1PiQO ludwigshafen and a 1 PiM mineral springs produce more complex patterns when analyzed by TUG electrophoresis. In each case, however, a prominent band that appears to correspond to that observed for the wild type protein is present. The two major bands appearing in the patterns generated from analyses of these variants, especially in the case of the cellular material, converge as the urea concentration increases indicating that the forms responsible for each of the bands unfold to yield the same denatured state at the higher urea concentrations. Based on the results of these analyses, the unfolding of a 1 PiM and a 1 PiW bethesda in the presence of increasing concentrations of urea seems identical. The more complex patterns observed for a 1 PiQO ludwigsbafen and a 1 PiM mineral springs are similar to each other but clearly differ from those of a 1 PiM and a 1 PiW bethesda .
The results of analyses of the category 2 variants, a 1 PiI and a 1 PiP lowell , by TUG electrophoresis are shown in Fig.  10 . The patterns observed for the cellular and secreted forms of a 1 PiP lowell are not significantly different from those observed for wild type a 1 Pi (Fig. 9) indicating that the stability of this variant to urea denaturation is not altered by the mutation. The other category 2 variant, a 1 PiI, however, produces two distinct bands after TUG electrophoresis. The two bands fail to converge at the higher urea concentrations indicating that complete unfolding of one of the forms, probably the lower band, fails to occur even at 8 M urea.
The TUG electrophoretic analyses of the poorly secreted, category 3, variants of a 1 Pi are shown in Fig. 11 . In all cases, the patterns are complex and clearly differ from the patterns exhibited by wild type a 1 Pi. Portions of each of these variants apparently aggregate as indicated by the multiple bands that exhibit little change in mobility as the urea concentration increases and by the presence of significant amounts of immunoreactive material that fail to enter the gels or that enter slowly but fail to migrate as distinct bands. In some cases, more of the aggregated material is observed at the lower urea concentrations suggesting that partial dissolution of the aggregates may occur as the concentration of urea increases. These results indicate that relative to wild type a 1 Pi, the single amino acid substitutions in the category 3 variants cause structural changes that lead to the complex unfolding patterns and to the heterogeneity observed.
Discussion
These studies compare the effects of miss-sense mutations causing single changes in the primary structure of human a 1 Pi on the properties of the eight different, rare variants of this protease inhibitor. These variants have been reported to increase the risk of pulmonary disease in individuals that express them homozygously or in heterozygous combination with another deficiency variant. Other investigators previously identified the base changes responsible for the mutations by DNA sequence analyses and partially characterized the variants. In many cases, however, cDNAs encoding the single amino acid replacements were not constructed and expressed, or if expressed, different systems were frequently utilized. To systematically evaluate the effects of these single amino acid replacements on each of these variants, all mutations were made in a cDNA originally encoding the normal M2 variant of a 1 Pi, all constructs, except for the base changes required to produce the mutant, were identical, and the cDNAs were all expressed in COS-1 cells. a 1 PiW bethesda (A 336 YT) was originally observed in an individual identified as a aPiSW bethesda heterozygote [22] . The serum level of a 1 Pi in the index case was in the low normal range and no pulmonary disease was reported for this individual. Our results support the conclusion that a 1 PiW bethesda does not accumulate in cells expressing this variant and failure to accumulate is due to efficient secretion rather than to post-translational degradation. All of our data relevant to the properties of this variant, rate of secretion, lack of intracellular degradation, efficient formation of a SDS-stable adduct with elastase, intracellular distribution, and susceptibility to unfolding in urea support the idea that W bethesda is a normal allelic variant of a 1 Pi.
The a 1 PiM mineral springs (G 67 YE) allele was identified in a homozygous individual diagnosed with pulmonary emphysema [19] . Previous observations lead to the conclusion that pulmonary disease may result in individuals heterozygous for this variant due to a combination of reduced ability to inhibit elastase and to decreased serum levels caused by inefficient secretion. Our characterization of a 1 PiM mineral springs produced in transiently transfected COS cells show that, in this case, this variant is secreted at about the same rate as wild type a 1 Pi. The lack of formation of a SDS-stable complex between a 1 PiM mineral springs and elastase accurately shows that this variant is a poor inhibitor of elastase. Since the serum level of a 1 PiM mineral springs observed in the proband was high enough to protect the lungs, we suspect that any role of the inhibitor in the onset of emphysema is related to a dramatic reduction in its ability to inhibit elastase rather than a problem with its secretion.
Frazier et al. [20] identified a 1 PiQO ludwigshafen in a proband of Pi type QO ludwigshafen Z. The entire coding region, all intron/exon junctions and a portion of the hepatocyte transcriptional control region [34] were sequenced [20] . Only one base change that resulted in an amino acid replacement, I 92 YN, was detected. This individual had only about 13% of the normal serum levels of a 1 Pi and all of the circulating inhibitor was identified as a 1 PiZ. The absence of a 1 PiQO ludwigshafen from the serum was attributed to an altered tertiary structure that caused a destabilization of the protein, but no data substantiating this idea were presented. However, we found that this variant is stable when expressed in transiently transfected COS cells and that it is efficiently secreted from these cells. Based on the observation that very little SDS-stable complex is formed between this variant and elastase, we suspect that it has limited ability to inhibit this protease and that an individual expressing a 1 PiQO ludwigsnafen homozygously or in combination with other variants known to be associated with pulmonary disease is at risk for developing emphysema.
A single base change converting the codon GAT to GTT resulting in the replacement of Asp 256 by Val has been reported in two families [21, 35] . In one case, the variant is termed Null Cardiff [16] and in the other P lowell [21] . In both cases, the variants were identified in PiP lowell Z heterozygotes that were diagnosed with pulmonary disease but showed no symptoms of liver disease. Low serum levels of a 1 Pi were measured resulting in the designation of this variant as an ''at risk'' allele [21] . Our results are consistent with the notion that a 1 PiP lowell is stable within the cell and that it is secreted more slowly than a 1 PiM. Relative to the secreted material, the ability of the intracellular form of a 1 PiP lowell to form a SDS-stable complex with elastase is reduced. The secreted form, however, appears to produce stable SDS-complexes with elastase as well as a 1 PiM. Little differences in stability to urea denaturation were observed between wild type and the mutant.
The a 1 PiI variant (R 39 YC) [16] was identified in a family studied due to failure to detect an a 1 Pi-peak upon routine serum electrophoresis of one of the relatives with coronary artery disease [36] . This individual, who was identified as an IZ heterozygote, experienced recurring bronchitis but lung function tests were essentially normal. Though emphysema was not diagnosed in this individual, the I allele is considered an ''at-risk'' allele [37] . The results of our studies show that this variant: is secreted more slowly than a 1 PiM; is not degraded to a significant extent within these cells; is efficiently complexed with elastase; and that the secreted form produces a more complex pattern than the corresponding form of a 1 PiM when analyzed by TUG electrophoresis. This indicates heterogeneity in the mature form of a 1 PiI, and that the stability of this variant differs from a 1 PiM. Therefore, this altered stability may justify the ''at-risk'' classification.
The a 1 PiS iiyama variant (S 53 YF) was identified in a homozygous individual diagnosed with emphysema [18] . The serum level of a 1 Pi in this individual was well below that required to protect the lungs from the action of elastase. Inclusion bodies were noted upon examination of biopsy samples of the subject's liver but no liver disease was evident. The a 1 PiS iiyama mRNA level in leukocytes was found to be normal suggesting that transcription and stability of the mRNA were unaffected by the mutation. Subsequent studies on a 1 PiS iiyama partially purified from the plasma of the index case demonstrated that this protein had a pronounced tendency to polymerize and that these polymers were identical to those formed by a 1 Pi Z in vitro [38] . The poor secretion of the variant is due to intracellular accumulation of the protein. A 1 PiS iiyama does not form SDS stable complex with elastase, rather it serves as substrate for this enzyme. Our results support the notion that homozygous expression of the Siiyama allele or expression of this allele in combination with another deficiency allele increases the risk of developing pulmonary emphysema and, in susceptible individuals, liver disease.
The a 1 PiM procida variant (L 41 YP) was identified in a family that also harbored an a 1 PiNull allele [17] . The index case was a a 1 PiM procida Null individual diagnosed with emphysema. The serum level of a 1 Pi in this individual was extremely low, the circulating a 1 Pi was reported to be less active than normal, and the circulating half-life of a 1 PiM procida appeared to be normal. In addition, no accumulation of a 1 PiM prooida in the hepatocytes of the index case was observed. According to these results, the deficiency of circulating a 1 Pi in this individual was considered likely to be due to degradation of this protein prior to secretion. Our results suggest that a 1 PiM prooida may accumulate in the liver of susceptible individuals [12] , and thus, in some cases, may increase the risk of liver disease. The reduced secretion and the reduced ability of a 1 PiM procida to inhibit elastase provide a strong indication that homozygous expression of the M procida allele or expression of this allele in combination with another deficiency allele increases the risk of pulmonary disease.
The a 1 PiM heerlen variant (P 369 YL) was identified in a homozygous individual diagnosed with pulmonary disease [23] . The circulating level of a 1 Pi in this individual was determined to be 5 mg/100 ml serum, which is well below normal. The same mutation was observed in two heterozygous subjects from independent families who were found to have low circulating levels of a 1 Pi. Our results support the conclusion that the M heerlen allele is an ''at-risk'' allele for development of pulmonary disease and suggest that some individuals that express this allele may be at increased risk of liver disease.
In conclusion, our characterization of rare a 1 Pi variants produced in transiently transfected COS cells support the view that pulmonary disease associated with these variants may result from impaired secretion of this protein, from the inability of the variant to inhibit elastase, or may be due to a combination of both possibilities. These results provide the first detailed comparison of the effects of naturally occurring mutations on the properties of a 1 Pi.
